Home Elegen

Elegen

In operation
Series B
DNA Synthesis Technology Researcher
Basic
Enterprise Profile

Basic Information

Elegen is a developer of microfluidic technology aimed at disrupting synthetic biology. The company leverages rapid advancements in whole-genome engineering and DNA synthesizers to accelerate biomedical progress, enabling the healthcare industry to advance DNA sequence testing.
Elegen Corporation
California,United States of America
less than 15 people
January 01, 2017
info@elegenbio.com

Enterprise Profile

Industrial Sector
Biomanufacturing Information Technology Vendors Scientific Research and Experimental Development Services
Technology
Biotechnology Gene Synthesis Synthetic Biology